DAEWOONGPHARMACEUTICAL Stock Price & Chart

KRX: 069620 · 대웅제약 · KOSPI

₩128,300▲ ₩700 (+0.55%)at close · July 27, 2026
199,400105,000128,300Jul 03, 25Oct 10Jan 14Apr 20Jul 27, 26

DAEWOONGPHARMACEUTICAL (대웅제약, KRX: 069620) last closed at ₩128,300 on July 27, 2026, a +0.55% move on the day. Over the trailing 52 weeks the stock has traded between ₩105,000 and ₩199,400, a -21.96% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩128,300
Day change+0.55%
52-week high₩199,400
52-week low₩105,000

Key Fundamentals

FY 2026.03
Market cap₩1.49T
P/E (PER)7.59
P/B (PBR)1.47
EPS₩16,904
BPS₩87,439
ROE21.84%
Debt ratio112.30%
Rev. growth5.98%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.03) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Technical Snapshot

as of 2026-07-27
Weak BearishAlgorithmic summary of 5 standard indicators (net score -1). Describes current technical posture only — not a buy or sell recommendation.
  • ▲ Bullish20-day MAPrice above 125,430
  • ▼ Bearish60-day MAPrice below 128,533
  • ▼ Bearish120-day MAPrice below 145,938
  • ▼ BearishMA trend (20 vs 60)Short-term below mid-term
  • · NeutralRSI (14)RSI 44 — neutral zone
  • ▲ BullishMACD (12,26,9)MACD above signal
52-week position: 25% of rangeRSI(14): 445-day volume vs 20-day: -48%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

Reports mentioning DAEWOONGPHARMACEUTICAL

No daily reports have covered DAEWOONGPHARMACEUTICAL yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.